Sasha: ‘We realised that no one has taken the opportunity to develop the pathology industry in Malaysia, in terms of technology, and we want to be the ones to do that.’
Malaysian Genomics may be off investors’ radar, but hopes awareness of pathology will increase
SINCE its listing on the Ace Market of Bursa Malaysia back in 2010, Malaysian Genomics Resource Centre Bhd
(MGRC) seems to have fallen off the radar of investors.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
